(NASDAQ: KMDA) Kamada's forecast annual revenue growth rate of 7.88% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Kamada's revenue in 2025 is $167,235,000.On average, 3 Wall Street analysts forecast KMDA's revenue for 2025 to be $10,404,730,289, with the lowest KMDA revenue forecast at $10,351,940,671, and the highest KMDA revenue forecast at $10,450,964,334. On average, 3 Wall Street analysts forecast KMDA's revenue for 2026 to be $11,358,393,723, with the lowest KMDA revenue forecast at $11,046,141,405, and the highest KMDA revenue forecast at $11,625,792,117.
In 2027, KMDA is forecast to generate $12,003,600,171 in revenue, with the lowest revenue forecast at $11,893,190,511 and the highest revenue forecast at $12,114,009,830.